Advertisement
Canada markets close in 5 hours 1 minute
  • S&P/TSX

    21,909.03
    -102.69 (-0.47%)
     
  • S&P 500

    5,067.97
    -2.58 (-0.05%)
     
  • DOW

    38,412.60
    -91.09 (-0.24%)
     
  • CAD/USD

    0.7291
    -0.0029 (-0.40%)
     
  • CRUDE OIL

    83.01
    -0.35 (-0.42%)
     
  • Bitcoin CAD

    89,154.72
    -2,668.21 (-2.91%)
     
  • CMC Crypto 200

    1,402.73
    -21.37 (-1.50%)
     
  • GOLD FUTURES

    2,340.10
    -2.00 (-0.09%)
     
  • RUSSELL 2000

    1,996.84
    -5.80 (-0.29%)
     
  • 10-Yr Bond

    4.6670
    +0.0690 (+1.50%)
     
  • NASDAQ

    15,751.82
    +55.18 (+0.35%)
     
  • VOLATILITY

    15.96
    +0.27 (+1.72%)
     
  • FTSE

    8,041.01
    -3.80 (-0.05%)
     
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     
  • CAD/EUR

    0.6821
    -0.0015 (-0.22%)
     

Why Immunomedics Stock Skyrocketed 125% in April

Why Immunomedics Stock Skyrocketed 125% in April

Shares of biotech Immunomedics (NASDAQ: IMMU) skyrocketed 125% in April, according to data from S&P Global Market Intelligence. The FDA declined to approve the company's TNBC drug in January 2019 because of issues at the manufacturing plant where it was to be produced.